Effects of acetylsalicylic acid on serum paraoxonase activity, Ox-LDL, coenzyme Q10 and other oxidative stress markers in healthy volunteers

被引:23
作者
Kurban, Sevil [1 ]
Mehmetoglu, Idris [1 ]
机构
[1] Selcuk Univ, Meram Tip Fak, Biyokimya AD, TR-42080 Konya, Turkey
关键词
Acetylsalicylic acid; Paraoxonase; Arylesterase; Oxidized LDL; Coenzyme Q(10); Oxidative stress; LOW-DENSITY-LIPOPROTEIN; ASPIRIN; ATHEROSCLEROSIS; SUPEROXIDE; INHIBITION; SALICYLATE; EXPRESSION; INCREASES; DISEASE;
D O I
10.1016/j.clinbiochem.2009.10.054
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: The aim of the study was to examine the effects of acetylsalicylic acid (ASA) on oxidative stress in healthy volunteers. Design and Methods: 30 volunteers of which 17 received ASA as 100 mg/day (Group 1) and 13 received ASA as 150 mg/day (Group 11) for 2 months. Serum paraoxonase 1 (PON1), arylesterase, total antioxidant status (TAS), total oxidant status (TOS), oxidized LDL (Ox-LDL) and coenzyme Q(10) (CoQ(10)) levels were measured before and I and 2 months after treatment. Results: There was no significant differences between the measured parameters of the groups. However, TOS and Ox-LDL levels of group 11 were significantly reduced after 2 months of treatment (p<0.05). Conclusions: Significantly inhibition of LDL oxidation and significantly reduction in TOS levels of group II after 2 months of ASA treatment shows that ASA treatment may contribute to the prevention of atherosclerosis, a beneficial effect which is dose and time dependent. (C) 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:287 / 290
页数:4
相关论文
共 37 条
  • [1] Increases in tissue levels of ubiquinone in association with peroxisome proliferation
    Aberg, F
    Zhang, YY
    Teclebrhan, H
    Appelkvist, EL
    Dallner, G
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1996, 99 (1-3) : 205 - 218
  • [2] Anti-inflammatory effects of aspirin and sodium salicylate
    Amann, R
    Peskar, BA
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 447 (01) : 1 - 9
  • [3] Gentisic acid, an aspirin metabolite, inhibits oxidation of low-density lipoprotein and the formation of cholesterol ester hydroperoxides in human plasma
    Ashidate, K
    Kawamura, M
    Mimura, D
    Tohda, H
    Miyazaki, S
    Teramoto, T
    Yamamoto, Y
    Hirata, Y
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 513 (03) : 173 - 179
  • [4] Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development
    Aviram, M
    Rosenblat, M
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (09) : 1304 - 1316
  • [5] Aspirin
    Awtry, EH
    Loscalzo, J
    [J]. CIRCULATION, 2000, 101 (10) : 1206 - 1218
  • [6] Aspirin use is associated with higher serum concentrations of the anti-oxidant enzyme, paraoxonase-1
    Blatter-Garin, MC
    Kalix, B
    De Pree, S
    James, RW
    [J]. DIABETOLOGIA, 2003, 46 (04) : 593 - 594
  • [7] The paraoxonases: role in human diseases and methodological difficulties in measurement
    Camps, Jordi
    Marsillach, Judit
    Joven, Jorge
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2009, 46 (02) : 83 - 106
  • [8] Endothelial activation by angiotensin II through NFκB and p38 pathways:: Involvement of NFκB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin
    Costanzo, A
    Moretti, F
    Burgio, VL
    Bravi, C
    Guido, F
    Levrero, M
    Puri, PL
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2003, 195 (03) : 402 - 410
  • [9] Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirin
    Cyrus, T
    Yao, YM
    Tung, LX
    Praticò, D
    [J]. ATHEROSCLEROSIS, 2006, 184 (01) : 8 - 14
  • [10] Role of oxidative stress in cardiovascular diseases
    Dhalla, NS
    Temsah, RM
    Netticadan, T
    [J]. JOURNAL OF HYPERTENSION, 2000, 18 (06) : 655 - 673